A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

To be considered for this study, you would need to be 18 years old or older. Generally, you should be well enough to carry out most of your daily activities without much help, meaning you're quite active. Your body's organs, such as your liver and kidneys, need to be working properly. The type of cancer you have is important too. For some parts of the study, you would need to have advanced bowel or rectal cancer (called adenocarcinoma) that doctors can't remove with surgery. For other parts, you would need to have advanced prostate cancer (also adenocarcinoma) that has been confirmed by a biopsy.

There are also some reasons why you might not be able to join. For example, if you've had another type of cancer that needed treatment in the last two years, you might not be suitable, unless it was a very early skin cancer or a cancer that was completely removed and hasn't returned (like certain breast or bladder cancers). You also can't have had a major operation in the last month, or a serious infection in the last four weeks. If you have significant bleeding problems, untreated or growing brain tumours, or a certain type of lung problem (like severe scarring or inflammation), you might not be able to take part.

Furthermore, if you've had certain autoimmune diseases that needed strong medication in the last two years, or if you're taking medicines that suppress your immune system (unless it's a very low dose of steroids), you wouldn't be able to join. These rules are in place to help keep you safe and to make sure the study results are clear.

Taking part in this study means you would be given the new medicine, GSK5764227, in combination with other standard cancer treatments. This would likely involve regular visits to the hospital or clinic for your treatments and to have various checks and tests done. These tests might include blood tests, scans (like CT or MRI scans) to see how your cancer is responding, and possibly other procedures to monitor your health.

The specific number of visits and the total duration of your participation would depend on how you respond to the treatment and the stage of the study. You would receive the study medication as prescribed by the research team. Throughout the study, the doctors and nurses would keep a close eye on your health and any side effects you might experience. After your treatment phase, there would typically be a follow-up period to continue monitoring your health, even if you stop taking the study medication. All these details would be fully explained to you before you decide whether to join.